Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sirnaomics Ltd. ( (HK:2257) ) has shared an announcement.
Sirnaomics Ltd. has amended the terms of reference for its Nomination Committee, initially adopted in December 2021. The committee, which plays a crucial role in the governance of the company, is composed of at least three directors, with a majority being independent non-executive directors and at least one member of a different gender. This amendment underscores the company’s commitment to diversity and effective governance, potentially enhancing its industry positioning and stakeholder confidence.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biotechnology industry, focusing on the development of RNAi therapeutics. The company is known for its innovative approaches in creating treatments for various diseases, leveraging RNA interference technology.
Average Trading Volume: 185,497
Technical Sentiment Signal: Hold
Current Market Cap: HK$400.7M
For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.